
SPYGLASS PHARMA INC
SGP · NASDAQ
Updated at 2026-10-15 06:44:56
- Today's High
- $24.21
- Today’s Low
- $22.79
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $23.72
- Previous Close
- $23.69
- Volume
- 49.09K
- Market Cap
- $792.38M
- P/E Ratio
- --
- EPS
- $-3.37
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 15326 ALTON PARKWAY, IRVINE, CA, UNITED STATES, 92618
- Country
- US
- Listing Date
- 2026-02-06
- Fiscal Year End
- December
- Shares Outstanding
- 33.43M
- CIK
- --
- Website
- spyglasspharma.com
SpyGlass Pharma, Inc. (SGP) is a forward-thinking biopharmaceutical company focused on the development and commercialization of innovative therapies targeting significant health challenges. With a robust pipeline powered by advanced technologies, SGP aims to meet critical unmet medical needs and enhance patient outcomes. The company's strategic alliances not only bolster its market position but also accelerate its growth trajectory, making SGP a compelling investment prospect for institutional investors looking to capitalize on opportunities within the dynamic biopharmaceutical landscape.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$21.62M
2026-03-31
$15.09M
2025-12-31
$13.41M
2025-09-30
$11.1M
Net Income
2026-06-30
-$19.86M
2026-03-31
-$13.81M
2025-12-31
-$12.55M
2025-09-30
-$9.81M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.59
2026-03-31
$-0.69
2025-12-31
$-0.37
2025-09-30
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$21.62M
2026-03-31
-$13.5M
2025-12-31
-$12.33M
2025-09-30
-$10.96M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $21.62M | $15.09M | $13.41M | $11.1M |
| Net Income | -$19.86M | -$13.81M | -$12.55M | -$9.81M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.59 | $-0.69 | $-0.37 | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$21.62M | -$13.5M | -$12.33M | -$10.96M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.